Filing metadata

Accession number
0001209191-22-051046
Form type
Form 3
Filer
Janux Therapeutics, Inc.
CIK
CIK 1817713
Filed
Sep 22, 2022
Reporting period
Sep 21, 2022
Description
Initial ownership

Explore SEC Filings Hub